Related references
Note: Only part of the references are listed.The-1195G Allele Increases the Transcriptional Activity of Cyclooxygenase-2 Gene (COX-2) in Colon Cancer Cell Lines
Carina Pereira et al.
MOLECULAR CARCINOGENESIS (2014)
Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility
Cheryl L. Thompson et al.
PLOS ONE (2013)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation
A. E. Moore et al.
ONCOGENE (2012)
Factors Influencing Colorectal Cancer Screening Participation
Antonio Z. Gimeno Garcia
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22
A. Abuli et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Polymorphisms in fatty acid metabolism-related genes are associated with colorectal cancer risk
Birgit Hoeft et al.
CARCINOGENESIS (2010)
COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention
Carina Pereira et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression
Masashi Sakaki et al.
HEPATOLOGY RESEARCH (2010)
Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?
Carina Pereira et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
COX-2 Polymorphisms in Patients With Familial Adenomatous Polyposis
Wilbert H. M. Peters et al.
ONCOLOGY RESEARCH (2009)
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
Min Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of Prostaglandin Transporters in Colorectal Neoplasia
Vijaykumar R. Holla et al.
CANCER PREVENTION RESEARCH (2008)
Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk:: The self defense forces health study
Naoyuki Ueda et al.
CANCER SCIENCE (2008)
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer
Wen Tan et al.
CARCINOGENESIS (2007)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation
Helen Pui Shan Wong et al.
TOXICOLOGICAL SCIENCES (2007)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Seung-Jae Myung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genetic variants in cyclooxygenase-2:: Expression and risk of gastric cancer and its precursors in a Chinese populationc
Fen Liu et al.
GASTROENTEROLOGY (2006)
The role of prostaglandins and other eicosanoids in the gastrointestinal tract
DZ Wang et al.
GASTROENTEROLOGY (2005)
15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer
MG Backlund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts:: implications for lung inflammation and cancer
CA Martey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
G Reid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prostaglandin catabolizing enzymes
HH Tai et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Prostaglandin transport
VL Schuster
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Benzo[α]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells -: Evidence for the involvement of extracellular signal-regulated kinase and NF-κB
ZP Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
